Israel
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
5.81%
|
Dec. 31, 2023 | USD 6.96 | 3.55% |
|
Israel |
|
2 |
-4.85%
|
Dec. 31, 2023 | USD 2.37 | 3.33% |
|
Israel |
|
3 |
-10.15%
|
Dec. 31, 2023 | USD 0.02 | -4.22% |
|
Israel |
|
4 |
-56.05%
|
Dec. 31, 2023 | USD 2.38 | 4.02% |
|
Israel |
|
5 |
-56.82%
|
Dec. 31, 2023 | USD 2.86 | -0.54% |
|
Israel |
|
6 |
-200.97%
|
Dec. 31, 2023 | USD 0.11 | 3.21% |
|
Israel |
|
7 |
-1,262.79%
|
Dec. 31, 2023 | USD 0.01 | -3.84% |
|
Israel |
The Vaccines company in Israel with the highest Net Income Margin is Kamada Ltd. (Tel Aviv Stock Exchange: KMDA.TA) at 5.81%.
The Vaccines company in Israel with the lowest Net Income Margin is BioLineRx Ltd. (Tel Aviv Stock Exchange: BLRX.TA) at -1,262.79%.
The top 10 Vaccines companies in Israel by Net Income Margin are Kamada Ltd., Bait Vegag Real Estate Development Ltd, Purple Biotech Ltd., Compugen Ltd., Epitomee Medical Ltd, Tikun Olam-Cannbit Pharmaceuticals Ltd and BioLineRx Ltd..
The bottom 10 Vaccines companies in Israel by Net Income Margin are BioLineRx Ltd., Tikun Olam-Cannbit Pharmaceuticals Ltd, Epitomee Medical Ltd, Compugen Ltd., Purple Biotech Ltd., Bait Vegag Real Estate Development Ltd and Kamada Ltd..